111 related articles for article (PubMed ID: 37378424)
21. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
22. PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
Zhang S; Zhou Y; Zha Y; Yang Y; Wang L; Li J; Jin W
Mol Med Rep; 2018 Jul; 18(1):715-722. PubMed ID: 29845265
[TBL] [Abstract][Full Text] [Related]
23. Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R).
Zheng SW; Wan WG; Miao HX; Tang R; Wang B; Huang QZ; Liu WL; Zheng JP; Chen CQ; Zhong HB; Li SF; Sun CH
Med Sci Monit; 2017 Aug; 23():4132-4140. PubMed ID: 28844074
[TBL] [Abstract][Full Text] [Related]
24. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
[TBL] [Abstract][Full Text] [Related]
26. MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway.
Lin JL; Chen HC; Fang HI; Robinson D; Kung HJ; Shih HM
Oncogene; 2001 Oct; 20(45):6559-69. PubMed ID: 11641781
[TBL] [Abstract][Full Text] [Related]
27. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J
Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239
[TBL] [Abstract][Full Text] [Related]
28. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
29. LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression.
Yao W; Hou J; Liu G; Wu F; Yan Q; Guo L; Wang C
Cancer Biomark; 2023; 36(1):1-16. PubMed ID: 35912730
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
31. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Cheng DD; Lin HC; Li SJ; Yao M; Yang QC; Fan CY
Sci Rep; 2017 Apr; 7():46238. PubMed ID: 28387323
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis.
Zhang Q; Geng PL; Yin P; Wang XL; Jia JP; Yao J
Asian Pac J Cancer Prev; 2013; 14(4):2311-5. PubMed ID: 23725133
[TBL] [Abstract][Full Text] [Related]
33. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
[TBL] [Abstract][Full Text] [Related]
34. MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1.
Gong Y; Wei ZR
BMC Cancer; 2022 Aug; 22(1):934. PubMed ID: 36038837
[TBL] [Abstract][Full Text] [Related]
35. [Role of SCUBE3 in promoting osteosarcoma cell growth and its association with prognosis].
Song G; Wang J; Lu J; Xu H; Zhao Z; Tang Q; Zou C; Yin J; Xie X; Shen J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):617-21. PubMed ID: 24849422
[TBL] [Abstract][Full Text] [Related]
36. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
37. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
39. Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking.
Susa M; Choy E; Liu X; Schwab J; Hornicek FJ; Mankin H; Duan Z
Mol Cancer Ther; 2010 Dec; 9(12):3342-50. PubMed ID: 20881269
[TBL] [Abstract][Full Text] [Related]
40. Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.
Pi WS; Cao ZY; Liu JM; Peng AF; Chen WZ; Chen JW; Huang SH; Liu ZL
Technol Cancer Res Treat; 2018; 18():1533033819853262. PubMed ID: 31122179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]